These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11338500)

  • 21. Polysaccharide antigens of Pseudomonas aeruginosa.
    Knirel YA
    Crit Rev Microbiol; 1990; 17(4):273-304. PubMed ID: 1698385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The biology of endotoxin.
    el-Samalouti VT; Hamann L; Flad HD; Ulmer AJ
    Methods Mol Biol; 2000; 145():287-309. PubMed ID: 10820728
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cytokine-stimulating activity of lipopolysaccharide of gram-negative bacteria and its role in antitumor immunity].
    Riabichenko EV; Bondarenko VM; Vetkova LG
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (6):76-81. PubMed ID: 16438384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of experimental gram-negative bacterial sepsis with murine monoclonal antibodies directed against lipopolysaccharide.
    Priest BP; Brinson DN; Schroeder DA; Dunn DL
    Surgery; 1989 Aug; 106(2):147-54; discussion 154-5. PubMed ID: 2763023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MIF regulates innate immune responses through modulation of Toll-like receptor 4.
    Roger T; David J; Glauser MP; Calandra T
    Nature; 2001 Dec 20-27; 414(6866):920-4. PubMed ID: 11780066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial virulence factors--with particular reference to Salmonella bacteria.
    Lindberg AA
    Scand J Infect Dis Suppl; 1980; Suppl 24():86-92. PubMed ID: 6111123
    [No Abstract]   [Full Text] [Related]  

  • 27. Properties of bacteria that trigger hemocytopenia in the Atlantic blue crab, Callinectes sapidus.
    Johnson NG; Burnett LE; Burnett KG
    Biol Bull; 2011 Oct; 221(2):164-75. PubMed ID: 22042435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation and immunogenicity of a potential multivalent type III secretion system-based protein vaccine.
    Markham AP; Barrett BS; Esfandiary R; Picking WL; Picking WD; Joshi SB; Middaugh CR
    J Pharm Sci; 2010 Nov; 99(11):4497-509. PubMed ID: 20845449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and neutrophil adhesion.
    Darveau RP; Cunningham MD; Seachord CL; Page RC; Aruffo A
    Prog Clin Biol Res; 1995; 392():69-78. PubMed ID: 8524966
    [No Abstract]   [Full Text] [Related]  

  • 30. [Role of lipopolysaccharide in the action of complement on gram negative bacteria].
    Lobanov VV
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (5):114-8. PubMed ID: 15554329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro cellular responses from sheep draining lymph node cells after subcutaneous inoculation with Salmonella abortusovis.
    Doucet F; Bernard S
    Vet Res; 1997; 28(2):165-78. PubMed ID: 9112738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation and characterization of a human monoclonal IgM antibody that recognizes a conserved epitope shared by lipopolysaccharides of different gram-negative bacteria.
    Seifert M; Schoenherr G; Roggenbuck D; Marx U; von Baehr R
    Hybridoma; 1996 Jun; 15(3):191-8. PubMed ID: 8823616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host-parasite interaction in serious infections due to gram-negative bacteria.
    Schellekens JF; Kalter ES; Vreede RW; Verhoef J
    Antonie Van Leeuwenhoek; 1984; 50(5-6):701-10. PubMed ID: 6397137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Aspects of the interrelationship between the infected host and the pathogenic agent].
    Clumeck N
    Ann Biol Clin (Paris); 1983; 41(6):397-401. PubMed ID: 6666881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
    J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biological characteristics of various strains of Pseudomonas aeruginosa isolated from human pathological matter].
    Costa AL; Amato A; Loteta A; Valenti A
    G Batteriol Virol Immunol; 1979; 71(1-6):55-61. PubMed ID: 114444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biosynthesis, transport, and modification of lipid A.
    Trent MS
    Biochem Cell Biol; 2004 Feb; 82(1):71-86. PubMed ID: 15052329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C1 inhibitor suppresses the endotoxic activity of a wide range of lipopolysaccharides and interacts with live gram-negative bacteria.
    Mejia P; Davis AE
    Shock; 2012 Aug; 38(2):220-5. PubMed ID: 22576004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli.
    Appelmelk BJ; Verweij-van Vught AM; Maaskant JJ; Schouten WF; De Jonge AJ; Thijs LG; Maclaren DM
    J Med Microbiol; 1988 Jun; 26(2):107-14. PubMed ID: 2455054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Kdo2-lipid A modification in gram-negative bacteria--a review].
    Wang X
    Wei Sheng Wu Xue Bao; 2013 Feb; 53(2):111-7. PubMed ID: 23627103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.